Alternatives to CureSign

AI-powered spatial biology platform for precision medicine and drug development.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Harnessing genetic data for digital insights in rare and germline disorders.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Developing novel diagnostics to predict patient response to immunotherapy.

Develops an endovascular solution for vasospasm treatment in aneurysmal subarachnoid hemorrhage.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Microbiome drug discovery company developing customized phage therapies for chronic diseases.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Developing AI-driven solutions for optimizing chronic condition treatment efficacy and tolerance.

Digital pathology imaging technology and AI-driven precision pathology software.

Develops toilet-integrated diagnostic technology for early health condition detection.

Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis.

Early-stage clinical company developing smart targeted radioligands for precision oncology.

Develops minimally invasive bioelectronic solutions for treating low back pain and spinal degeneration.

Biotechnology company personalizing medical cannabis treatment using metabolic biomarker analysis.

Global leader in enzymatic therapeutics for non-surgical tissue repair, replacing existing standards of care.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

Transforming healthcare by turning scientific fiction into scientific facts.

AI-powered blood analysis for precise substance tracing and classification in healthcare and research.

Developing engineered biologics to harness the immune system for disease treatment.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

AI-powered platform to predict and prevent adverse drug reactions, reducing hospitalizations.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Developing advanced bio-integrated devices for enhanced medical diagnostics and therapeutics.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Advanced diagnostics for preventative health and personalized cancer treatment using AI and genomics.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI-powered breast cancer detection and risk assessment solutions.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Developing ultrasound-mediated nonviral genetic medicines.

An end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials, focusing on lung and heart disease.

Pioneering vision restoration therapies for severe retinal degenerations.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

Immunotherapy company targeting oncology and autoimmune diseases.

Developing novel male contraceptives.

Develops a computational model of the human body for drug discovery and development.

Clinical-stage immunotherapy company developing novel treatments for cancer.

Develops and distributes bioreactor technology for stem cell cultivation.

Advancing targeted alpha therapies.

AI-powered multi-omics platform for early breast cancer detection and risk prediction.

Developing a new histotripsy therapeutic platform for cancer treatment.

Platform designed to cut cell and gene therapy production costs.

Elevating uterine health through innovative biomaterial therapies.